Cresset: Summary

Cresset

Pharmaceuticals, Drug Discovery, Computational Chemistry, Software Solutions

Cresset accelerates drug discovery by providing integrated in silico DMTA solutions that enhance decision-making and project performance.

Cresset provides software and services designed for small molecule discovery and design. Their solutions enhance drug discovery processes through integrated computational chemistry tools.

Agile ligand-based and structure-based drug design solution (Flare™); Scaffold hopping and R-group replacement for innovative discovery (Spark™); Ligand-based virtual screening to increase screening hit rates (Blaze™); Integrated DMTA solutions for tracking and managing compound synthesis

Cresset's services are most valuable for computational chemists, medicinal chemists, and research managers looking to enhance drug discovery efficiency and effectiveness.

Comprehensive software suite tailored for various aspects of drug design and discovery.; Expertise in computational chemistry that supports better design decisions.; Commitment to data security and compliance, ensuring trust and reliability.

Cresset's strengths lie in its robust software solutions, expert consultancy services, and a strong commitment to scientific integrity and customer success.

Cresset positions itself as a leader in computational chemistry solutions, focusing on enhancing drug discovery through innovative software and expert services.

The target users include computational chemists, medicinal chemists, biologists, and research managers who benefit from improved design decisions and project management.

REQUEST EVALUATION, DEMO OR DISCUSSION

• drug discovery

• computational chemistry

• software solutions

• molecule design

MAKE THE MOLECULES THAT MATTER

Professional, innovative, supportive

Cresset offers a unique perspective as a computational chemistry CRO, combining software tools with expert consultancy to advance drug discovery projects.

Cresset's brand identity emphasizes scientific credibility, customer commitment, and a mission to create a healthier world through advanced discovery solutions.

2002-01-01

• Andy Vinter

• Tim Cheeseright